© 2000 American Heart Association, Inc.
Molecular Medicine |
Novel Gain-of-Function Mechanism in K+ Channel–Related Long-QT Syndrome:
Altered Gating and Selectivity in the HERG1 N629D Mutant
From the Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Correspondence to H.J. Duff, Department of Medicine, University of Calgary, 3330 Hospital Dr, NW, Calgary, Alberta, Canada, T2N 4N1. E-mail hduff{at}ucalgary.ca
Abstract—The N629D mutation, adjacent to the GFG signature sequence of the HERG1 A K+ channel, causes long-QT syndrome (LQTS). Expression of N629D in Xenopus oocytes produces a rapidly activating, noninactivating current. N629D is nonselective among monovalent cations; permeation of K+ was similar to that of Na+ or Cs+. During repolarization to potentials between -30 and -70 mV, N629D manifested an inward tail current, which was abolished by replacement of extracellular Na+ (Na+e) with extracellular N-methyl-D-glucamine (NMGe). Because LQTS occurs in heterozygous patients, we coexpressed N629D and wild type (WT) at equimolar concentrations. Heteromultimer formation was demonstrated by analyzing the response to 0 [K+]e. The outward time-dependent current was nearly eliminated for WT at 0 [K+]e, whereas no reduction was observed for homomultimeric N629D or for the equimolar coexpressed current. To assess physiological significance, dofetilide-sensitive currents were recorded during application of simulated action potential clamps. During phase 3 repolarization, WT manifested outward currents, whereas homomultimeric N629D manifested inward depolarizing currents. During coexpression studies, variable phenotypes were observed ranging from a reduction in outward repolarizing current to net inward depolarizing current during phase 3. In summary, N629D replaces the WT outward repolarizing tail current with an inward depolarizing sodium current, which is expected to delay later stages of repolarization and contribute to arrhythmogenesis. Thus, the consequences of N629D resemble the pathophysiology seen in LQT3 Na+ channel mutations and may be considered the first LQTS K+ channel mutation that exhibits gain of function.
Key Words: long-QT syndrome • HERG1 • K+ channel • gain of function
This article has been cited by other articles:
 |
|
 |
|
  T. A. Beery, K. A. Shooner, and D. W. Benson Neonatal Long QT Syndrome Due to a De Novo Dominant Negative hERG Mutation Am. J. Crit. Care., July 1, 2007; 16(4): 416 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Anderson, B. P. Delisle, B. D. Anson, J. A. Kilby, M. L. Will, D. J. Tester, Q. Gong, Z. Zhou, M. J. Ackerman, and C. T. January Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism Circulation, January 24, 2006; 113(3): 365 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Clancy and R. S. Kass Inherited and Acquired Vulnerability to Ventricular Arrhythmias: Cardiac Na+ and K+ Channels Physiol Rev, January 1, 2005; 85(1): 33 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Delisle, B. D. Anson, S. Rajamani, and C. T. January Biology of Cardiac Arrhythmias: Ion Channel Protein Trafficking Circ. Res., June 11, 2004; 94(11): 1418 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Teng, X. Zhao, J. C Cross, P. Li, J. P Lees-Miller, J. Guo, J. R.B Dyck, and H. J Duff Prolonged repolarization and triggered activity induced by adenoviral expression of HERG N629D in cardiomyocytes derived from stem cells Cardiovasc Res, February 1, 2004; 61(2): 268 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Thomas, J. Kiehn, H. A Katus, and C. A Karle Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing Cardiovasc Res, November 1, 2003; 60(2): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hajdu, C. Ulens, G. Panyi, and J. Tytgat Drug- and mutagenesis-induced changes in the selectivity filter of a cardiac two-pore background K+ channel Cardiovasc Res, April 1, 2003; 58(1): 46 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Q. Teng, J. P Lees-Miller, Y. Duan, B.-T. Li, P. Li, and H. J Duff [K+]o-dependent change in conformation of the HERG1 long QT mutation N629D channel results in partial reversal of the in vitro disease phenotype Cardiovasc Res, March 1, 2003; 57(3): 642 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Paulussen, A. Raes, G. Matthijs, D. J. Snyders, N. Cohen, and J. Aerssens A Novel Mutation (T65P) in the PAS Domain of the Human Potassium Channel HERG Results in the Long QT Syndrome by Trafficking Deficiency J. Biol. Chem., December 6, 2002; 277(50): 48610 - 48616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. R. Roti, C. D. Myers, R. A. Ayers, D. E. Boatman, S. A. Delfosse, E. K. L. Chan, M. J. Ackerman, C. T. January, and G. A. Robertson Interaction with GM130 during HERG Ion Channel Trafficking. DISRUPTION BY TYPE 2 CONGENITAL LONG QT SYNDROME MUTATIONS J. Biol. Chem., November 27, 2002; 277(49): 47779 - 47785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rajamani, C. L. Anderson, B. D. Anson, and C. T. January Pharmacological Rescue of Human K+ Channel Long-QT2 Mutations: Human Ether-a-Go-Go-Related Gene Rescue Without Block Circulation, June 18, 2002; 105(24): 2830 - 2835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hayashi, M. Shimizu, H. Ino, M. Yamaguchi, H. Mabuchi, N. Hoshi, and H. Higashida Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome Cardiovasc Res, April 1, 2002; 54(1): 67 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ficker, C. A. Obejero-Paz, S. Zhao, and A. M. Brown The Binding Site for Channel Blockers That Rescue Misprocessed Human Long QT Syndrome Type 2 ether-a-gogo-related Gene (HERG) Mutations J. Biol. Chem., February 8, 2002; 277(7): 4989 - 4998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Clancy and Y. Rudy Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death Cardiovasc Res, May 1, 2001; 50(2): 301 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. C. Hoppe, E. Marban, and D. C. Johns Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1 PNAS, April 24, 2001; 98(9): 5335 - 5340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. M. Wilde and D. M. Roden Predicting the Long-QT Genotype From Clinical Data : From Sense to Science Circulation, December 5, 2000; 102(23): 2796 - 2798. [Full Text] [PDF]
|
|
|
|
|
|
G. A. Robertson LQT2 : Amplitude Reduction and Loss of Selectivity in the Tail That Wags the HERG Channel Circ. Res., March 17, 2000; 86(5): 492 - 493. [Full Text] [PDF]
|
|